Intrinsiqq
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. Dividend Analysis

HRMY

Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Harmony Biosciences Holdings (HRMY) pay a dividend?

Harmony Biosciences Holdings (HRMY) has never paid a dividend. The business does generate free cash flow of $323 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Harmony Biosciences Holdings (HRMY) pay a dividend?+

No. Harmony Biosciences Holdings (HRMY) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Harmony Biosciences Holdings return cash to shareholders?+

It largely does not. Harmony Biosciences Holdings pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Harmony Biosciences Holdings afford to pay a dividend?+

On the numbers, yes. Harmony Biosciences Holdings generated $323 million of free cash flow, which is about $5.41 per share. If it paid out half of that, the dividend would be roughly $2.71 per share, a yield of about 8.3% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Harmony Biosciences Holdings.

SourceDividend analysis computed from the 10-Q filed 2 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 5 Nov 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Pharmaceutical Preparations · Pick stocks to compare with HRMY

CompareIntrinsic value
ANIPAni Pharmaceuticals Inc.
$68.55-0.84%85
CORTCorcept Therapeutics Incorporated
$63.62-2.09%56
KNSAKiniksa Pharmaceuticals International, plc
$93.90+0.38%71
BBIOBridgeBio Pharma, Inc.
$76.03-2.75%30
PBHPrestige Consumer Healthcare Inc.
$49.63+0.06%48
IONSIonis Pharmaceuticals, Inc.
$26.58-2.35%40
APLSApellis Pharmaceuticals, Inc.
$2.94+0.67%84
AXSMAxsome Therapeutics, Inc.
$129.36-4.66%10

Held by ETFs

HRMY is in 103 US ETFs. The largest of them, with HRMY's weight in each:

Spot a number that looks wrong? Check it in HRMY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HRMY

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.